Investments
Kurma Partners Secures €140M for Biofund IV, Aiming for €250M to Fuel European Healthcare Innovation
Kurma Partners, Biofund IV, Healthcare Innovation, Venture Capital, European Biotech, Healthcare Investment
Johnson & Johnson Invests $2 Billion in New North Carolina Biologics Facility
Johnson & Johnson, North Carolina, Biologics Facility, Pharmaceutical Manufacturing, Investment
Bristol Myers Squibb Invests $110 Million in T-Cell Therapy Pact with Prime Medicine
Bristol Myers Squibb (BMS), Prime Medicine, T-cell therapy, Ex vivo therapies, Biotech investment, Pharmaceutical partnerships
Aktis Oncology Secures $175M Series B Funding with Backing from Industry Giants
Aktis Oncology, Series B funding, targeted alpha radiopharmaceuticals, cancer treatment, pharmaceutical industry, investment, Lilly, BMY, MRK.
CDMO Serán Secures $200M Investment from Bain Capital to Establish First Commercial Facility
CDMO Serán, Bain Capital, commercial facility, biopharmaceutical manufacturing, investment
Bristol Myers Terminates Partnership with Immatics on Bispecific Cancer Drug After $150M Investment
Bristol Myers Squibb, Immatics, bispecific cancer drug, partnership termination, $150M investment
Eli Lilly Expands Irish Manufacturing with Additional $1B Investment
Eli Lilly, Ireland, manufacturing expansion, biologics, pharmaceuticals, investment, Limerick, Kinsale
Superluminal Medicines Secures $120M Series A Funding to Advance Membrane Receptor Drugs into Clinical Trials
Superluminal Medicines, Series A funding, membrane receptor drugs, clinical trials, AI-focused biotech, Eli Lilly investment
Novartis Expands Radioligand Therapy Manufacturing with $200M Investment in Two US Sites
Novartis, radioligand therapy, manufacturing expansion, $200M investment, California, Indianapolis
ArsenalBio Secures $325M in Series C Funding for Solid Tumor Cell Therapy Trials
ArsenalBio, cell therapy, solid tumor trials, Series C funding, biotech investment